Methods of treating chronic inflammatory diseases using a GM-CSF antagonist

Details for Australian Patent Application No. 2012202240 (hide)

Owner KaloBios Pharmaceuticals, Inc.

Inventors Bebbington, Christopher R.; Yarranton, Geoffrey T.

Agent Pizzeys

Pub. Number AU-A-2012202240

Parent 2007323541

Filing date 18 April 2012

Wipo publication date 10 May 2012

International Classifications

A61K 31/519 (2006.01) - ortho- or peri-condensed with heterocyclic rings

A61K 31/505 (2006.01) - Pyrimidines

A61K 39/00 (2006.01) Medicinal preparations containing antigens or antibodies

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

Event Publications

3 May 2012 Complete Application Filed

10 May 2012 Application Open to Public Inspection

  Published as AU-A-2012202240

9 August 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under Reg. 22.2B(2). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2012202241-An Interactive Media Guidance System Having Multiple Devices

2012202239-Railroad freight car draft gear